Industry Sponsored Sessions

Saturday, June 4

---

 14.30 - 16.00

Industry Sponsored Symposium: Alcon
ISS01 Next generation of medical therapies

Moderators: Christophe Baudouin, France
                     Gabor Hollo, Hungary

Co-morbidities in glaucoma care
Maurizio Rolando, Italy

The good, the bad and the ugly
Antoine Labbe, France

New therapeutic treatment options
Ingeborg Stalmans, Belgium

Medical therapies: consider what is important
Norbert Pfeiffer, Germany

Adherence and persistence: improvable?
Tarek Shaarawy, Switzerland

---

 

 

 16.30 - 18.00

Industry Sponsored Symposium: Novartis
ISS02 New Horizons: treating visual impairment due to diabetic macular oedema

Moderator: Francesco Bandello, Italy

Welcome and introduction
Francesco Bandello, Italy

New options: ranibizumab  in visual impairment due to DME
Gabriele Lang, Germany

Sustained patient benefit: two year outcomes with ranibizumab in visual impairment due to DME
Susan Bressler

Supporting optimized individual patient treatment in visual impairment due to DME
Christian Prünte, Switzerland

Panel discussion
All faculty

Summary and close
Francesco Bandello, Italy 
 

 

Sunday, June 5

---

 10.15 - 11.45

Industry Sponsored Symposium: Santen
ISS03 Preserve vision not the drops

Moderator: Tarek Shaarawy, Switzerland

Optimal medical therapy for glaucoma patients with dry eye
Carl Erb, Germany

Meta-analysis on switching from preserved prostaglandin to preservative-free prostaglandin
Hannu Uusitalo, Finland

Diurnal IOP measurement – what is new
Shibal Bhartiya, Switzerland

How to improve the success rate of glaucoma surgeries
Tarek Shaarawy, Switzerland

---

 12.00 - 13.00

Industry Sponsored Symposium: Bausch+Lomb
ISS04 New advances in inflammation control post cataract surgery

Moderator: Oliver Findl, Austria

Ocular inflammation post cataract surgery
Paul Ursell, United Kingdom

Optimising cataract surgery outcomes with NSAIDs
Pierogiorgio Neri, Italy

Bromfenac – a new standard in NSAID efficacy
Oliver Findl, Austria

Panel discussion and concluding remarks

---

 14.30 - 16.00

Industry Sponsored Symposium: Bausch+Lomb
ISS05 Nutrition yesterday and today: can we see clearer?

Moderator: Anita Leys, Belgium

How has nutrition evolved over time?
Anne Till, South Africa

Pathophysiology of age-related macular degeneration
Ian Grierson, United Kingdom

AMD - do nutritionals play a role?
Anita Leys, Belgium

Panel discussion and concluding remarks

Monday, June 6

---

 10.15 - 11.45

Industry Sponsored Symposium: Pfizer
ISS06 New approaches in the care of paediatric glaucoma

Moderator: Norbert Pfeiffer, Germany

The epidemiology and pathogenesis of paediatric glaucoma
John Brookes, United Kingdom

Current approaches and challenges to paediatric glaucoma management
John Thygesen, Denmark

New developments in the management of paediatric glaucoma
Peng Khaw, United Kingdom

From paediatric to adult glaucoma: what can we learn from paediatric studies?
Norbert Pfeiffer, Germany

General Q & A and close
Norbert Pfeiffer, Germany

---

 12.00 - 13.00

Industry Sponsored Symposium: Allergan
ISS07 Treatment paradigms for macular oedema following  RVO and uveitis

Moderators:   Gabriel Coscas, France
                       Francesco Bandello, Italy

Welcome
Gabriel Coscas, France
Francesco Bandello, Italy

Current standard and new guidelines for management of RVO in Europe
Anat Loewenstein, Israel

Why are steroids useful in management of RVO
Baruch Kuppermann, United States

Duration of retinal disease and management outcomes –
food for thought?
Francesco Bandello, Italy

Advances in management of Uveitis and Treatment algorithms  
Marc de Smet, Switzerland

Discussion
All faculty